From the COVID-19 pandemic to brolucizumab safety concerns, here's a look at the year's most-viewed clinical news stories and Editors' Choice coverage.

This retrospective, multicenter, single-arm study assessed the 1-year outcomes of sequential canaloplasty and trabeculotomy with the OMNI surgical system.

In this presentation from AGS 2020, Dr. Keith Barton discusses bleb needling and bleb revision of the XEN Gel Stent, a MIGS device for open-angle glaucoma.

In this presentation from AGS 2020, Dr. Carla Siegfried describes surgical techniques and concepts that lead to a successful trabeculectomy bleb, including conjunctival closure and the use of mytomycin C (MMC).

In this presentation from AGS 2020, Dr. E. Randy Craven demonstrates the surgical techniques and outcomes that lead to a successful XEN bleb.

In this presentation from AGS 2020, Dr. Constance Okeke reviews minimally invasive glaucoma surgery (MIGS) options for patients with myopia. Because these patients have wide open angles, several MIGS procedures can work well, including goniotomy, stents, and canaloplasty.

This prospective study used in vivo anterior segment OCT imaging to assess the relationship between iStent positioning, iridocorneal angle structures and surgical outcomes.

This week, surgeons use stem cells to replace the ocular surface of chemical burn victims, Allergan bids farewell to TrueTear and scientists suspect face masks may promote dry eye disease.

This study assessed the relationship between retinal vessel density on OCT angiography and visual field sensitivity loss in highly myopic eyes with primary open-angle glaucoma (POAG).